QR Code Link to This Post
Schedule: One (1) scheduled study visit (up to 30-minutes long) at the ProMedDx facility in Norton, MA
Payment: $50 per 30-minute study visit for eligible participants, then an additional $50 when the colonoscopy results report is provided to ProMedDx
Details: Commercial clinical research organization located in Norton, MA seeks the following: healthy participants, 18 years of age or over, who are scheduled to have a routine colonoscopy procedure within 45 days after their study visit.
To be eligible for the study, each volunteer must be able to provide a copy of his/her colonoscopy results report. Volunteers who have a prior history of cancer or who are HIV-positive or Hepatitis A, B, or C-positive are not eligible for this study.
What you will be asked to do: If you volunteer and are eligible for enrollment in this study, you will be asked to sign an informed consent document. Thereafter, clinical research staff will collect information about your general medical history.
Approximately, 5 tablespoons (6 tubes) of blood will be collected from a vein in your arm by a clinical professional using a needle attached to a blood collection tube (just as would occur if you were undergoing routine blood collection at your doctor's office). After having the colonoscopy procedure, you will obtain a copy from your physician and provide the copy of the results to ProMedDx, who will remove your personal identifying information from the copy before sharing with medical researchers.
Study visits are conducted in a professional manner with utmost regard for your safety, privacy, and confidentiality.
Email us at show contact info or call show contact info to see if you qualify for this study.
About ProMedDx: Since 1998, with the assistance of our research participants, ProMedDx, an FDA Registered Blood Establishment, has made direct contributions to advancements in diagnostic testing leading to increased safety of the world's blood supply and less invasive methods for detection of various diseases including breast cancer and colorectal cancer. Our high quality specimens are collected under IRB-approved clinical protocols and adhere to ICH and GCP guidelines as well as HIPAA privacy regulations. ProMedDx clinical studies are conducted under an OHRP-approved Federal Wide Assurance (00023836).